Pharmaceuticals

Tumor Models Market Expansion Outlook: $3.23 Billion by 2029 Forecast

November 20, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Tumor Models Market By 2029?

The tumor model market has experienced rapid expansion in recent years. This market is projected to expand from $1.92 billion in 2024 to $2.13 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.3%. Historically, this expansion is linked to factors such as a rise in cancer cases, greater demand for personalized medicine, an escalating requirement for improved preclinical predictability, the increasing application of patient-derived xenograft models, and a heightened dependence on in vivo efficacy data.

The tumor model market size is anticipated to experience substantial expansion over the coming years. Its value is projected to reach $3.23 billion by 2029, achieving a compound annual growth rate (CAGR) of 10.9%. This forecasted growth is attributable to an increasing emphasis on human-relevant models, a rising demand for precision oncology, the proliferation of immuno-oncology, a growing need for high-throughput screening models, and a broadening interest in rare cancer models. Key trends for the forecast period include the evolution of three-dimensional (3D) cell culture models, ongoing pharmaceutical research and developments, continuous advancements in cell culture technology, the integration of AI into cancer modelling, and the development of patient-derived organoids.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27441&type=smp

Which Drivers Are Impacting The Tumor Models Market?

The expanding need for personalized medicine is projected to stimulate the growth of the tumor models market moving forward. Personalized medicine signifies a healthcare framework that utilizes an individual’s genetic and lifestyle details to customize treatments and care plans to their specific requirements. The emergence of personalized medicine is attributable to individuals favoring health technologies that offer real-time monitoring and treatment strategies uniquely designed for their biology. Tumor models support personalized medicine by functioning as experimental platforms that replicate the behavior of actual human cancers, allowing researchers and clinicians to test and predict how individual patients’ tumors will respond to specific treatments, thus enabling a more tailored therapeutic approach. For instance, in February 2023, as per the Personalized Medicine Coalition, a US-based professional membership organization, in 2022, the authorization of 12 new personalized medicines constituted approximately 34% of all newly approved therapies, indicating a significant increase from previous years. Therefore, the escalating demand for personalized medicine is propelling the expansion of the tumor models market.

How Is The Tumor Models Market Segmented?

The tumor models market covered in this report is segmented

1) By Type Of Tumor: Primary Tumor Models, Metastatic Tumor Models, Orthotopic Tumor Models, Heterotopic Tumor Models

2) By Application: Drug Discovery And Development, Cancer Research, Personalized Medicine, Toxicology Studies

3) By Technology: Xenograft Models, Genetically Engineered Mouse Models (GEMMs), Three-Dimensional (3D) Tumor Spheroids, Organ-On-A-Chip Models

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic Institutions, Contract Research Organizations (CROs), Government Research Organizations

Subsegments:

1) By Primary Tumor Models: Carcinoma Models, Sarcoma Models, Glioma Models, Melanoma Models, Leukemia Models, Lymphoma Models

2) By Metastatic Tumor Models: Lung Metastasis Models, Bone Metastasis Models, Liver Metastasis Models, Brain Metastasis Models, Lymph Node Metastasis Models

3) By Orthotopic Tumor Models: Orthotopic Breast Cancer Models, Orthotopic Lung Cancer Models, Orthotopic Pancreatic Cancer Models, Orthotopic Colon Cancer Models, Orthotopic Prostate Cancer Models

4) By Heterotopic Tumor Models: Subcutaneous Tumor Models, Intramuscular Tumor Models, Intraperitoneal Tumor Models

What Key Innovation Trends Are Fueling Advancements In The Tumor Models Market?

Leading companies in the tumor models market are concentrating on creating sophisticated solutions, like tumor spheroid models, to improve the physiological similarity and forecasting precision of in vitro cancer models. Tumor spheroid models are defined as three-dimensional (3D) clusters of cancer cells that naturally develop into spherical shapes within a culture environment. An illustration of this trend occurred in June 2024, when Predictive Oncology, a US-based firm specializing in advanced 3D cell culture technologies and predictive oncology solutions, introduced new 3D cell technology aimed at speeding up the discovery of cancer therapeutic drugs. This technology provides distinct functionalities including advanced 3D tumor spheroid and organoid models that closely imitate the tumor microenvironment, high-throughput screening capacities for swift drug evaluations, assistance for patient-specific personalized tumor models, thorough examination of drug entry into 3D structures, and incorporation with AI-powered data analytics for improved predictive accuracy and more profound understanding of therapeutic reactions.

Which Major Industry Participants Are Leading The Tumor Models Market Growth?

Major companies operating in the tumor models market are Merck & Co Inc., LabCorp Holdings Inc., Eurofins Scientific SE, WuXi AppTec Co Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Pharmaron Beijing Co. Ltd., The Jackson Laboratory, Taconic Biosciences Inc., Cyagen Biosciences Inc., Crown Bioscience Inc., Champions Oncology Inc., Reaction Biology Corporation, InSphero AG, Creative Biolabs Inc., Oncodesign S.A., Xentech S.A., MIMETAS BV, Experimental Pharmacology and Oncology Berlin-Buch GmbH, and Hera BioLabs Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/tumor-models-global-market-report

How Is Tumor Models Market Demand Varying Across Different Regions?

North America was the largest region in the tumor models market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor models market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Tumor Models Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27441&type=smp

Browse Through More Reports Similar to the Global Tumor Models Market 2025, By The Business Research Company

Voice Payment Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/voice-payment-software-global-market-report

Voice Banking Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/voice-banking-global-market-report

Voice Commerce Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/voice-commerce-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795